Neuroscience

A phase 3 study has found that an extended-release version of sodium oxybate reduces daytime sleepiness and attacks of muscle weakness in narcolepsy patients.

Stanford neuroscientists find that initial memory formation may involve both awareness of our location as well as what we were feeling when we were there.

Release of the brain’s equivalent of THC, marijuana’s active component, reduces seizure activity but leads to post-seizure oxygen deprivation in the brain, Stanford scientists and their collaborators have shown.

The Food and Drug Administration has approved a new and expensive medication for Alzheimer’s disease, but it’s not clear it helps. Researcher Kevin Schulman discusses what the government should consider before deciding to cover it.

A detailed molecular analysis of tissue from the brains of individuals who died of COVID-19 reveals extensive signs of inflammation and neurodegeneration, but no sign of the virus that causes the disease.

Artificial intelligence, interpreting data from a device placed at the brain’s surface, enables people who are paralyzed or have severely impaired limb movement to communicate by text.

Researchers at Stanford and KU Leuven have identified more than 70 genes that affect variation in both brain and facial structure. The genes don’t influence cognitive ability, further debunking beliefs that intelligence can be assessed by facial features.

Thanks to deep brain stimulation, an artist stricken with a common but lesser known neurological disorder called essential tremor can paint again with a steady hand.

Scientists have identified a key factor in mental aging and shown that it might be prevented or reversed by fixing a glitch in the immune system’s front-line soldiers.

A Stanford Medicine team used human stem cells to assemble a working nerve circuit connecting brain tissue to muscle tissue. The research could enable scientists to better understand neurological disorders that affect movement.

Annelise Barron, Peter Kim, Siddhartha Jaiswal and Keren Haroush will receive grants totaling $10 million to fund their investigations. The awards support risky efforts that could potentially have a big impact in the biomedical sciences.